Anzeige
Mehr »
Dienstag, 21.07.2026 - Börsentäglich über 12.000 News
+50% in 13 Tagen - Steht der große Ausbruch jetzt bevor?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3D5X9 | ISIN: CA64119M1059 | Ticker-Symbol: PF0
Tradegate
20.07.26 | 16:54
0,475 Euro
-2,86 % -0,014
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
NETRAMARK HOLDINGS INC Chart 1 Jahr
5-Tage-Chart
NETRAMARK HOLDINGS INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,4780,51616:27
0,4780,51416:00

Aktuelle News zur NETRAMARK Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
14.07.Netramark Holdings Inc: Netramark shareholders elect four directors at AGM13
13.07.Netramark Holdings Inc: Netramark hires AM Public Relations3
13.07.Stocks in Play: NetraMark Holdings Inc.6
13.07.NetraMark Holdings Inc.: NetraMark Engages AM Public Relations to Support Strategic Communications and Market Awareness381TORONTO, July 13, 2026 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the "Company" or "NetraMark") (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), an artificial intelligence company transforming clinical...
► Artikel lesen
09.07.Netramark Holdings Inc: Netramark lands contract research organization contract8
NETRAMARK Aktie jetzt für 0€ handeln
09.07.NetraMark secures first CRO partnership contract for AI analysis3
09.07.NetraMark sichert sich ersten KI-Analyse-Vertrag über CRO-Partnerschaft17
09.07.NetraMark Holdings Inc.: NetraMark Signs New Contract To Analyze Phase 2 Neurodegeneration Trial Data With Contract Research Organization Partner4
29.06.Netramark Holdings Inc: Netramark's NetraAI selected by biopharma company43
29.06.NetraMark Holdings Inc.: NetraMark Signs New NetraAI Clinical Trial Analysis Agreement with Late-Stage Biopharmaceutical Company392This agreement represents NetraMark's ninth commercial contract since the start of its current fiscal year and demonstrates growing interest in AI-enabled clinical trial analytics, like NetraAI, among...
► Artikel lesen
09.06.Stocks in Play: NetraMark Holdings Inc.44
20.05.Stocks in Play: NetraMark Holdings Inc.28
20.05.NetraMark Holdings Inc.: NetraMark to Present at the American Society of Clinical Psychopharmacology Annual Meeting38
14.05.NetraMark Holdings Inc.: NetraMark Provides Second Quarter Update and Highlights Continued Commercial, Scientific, Regulatory and Capital Markets Momentum579TORONTO, May 14, 2026 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the "Company" or "NetraMark") (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) a premier artificial intelligence (AI) company that is...
► Artikel lesen
08.05.Netramark Holdings Inc: Netramark Holdings director Guy resigns43
07.05.NetraMark board member Lawrence Guy resigns11
07.05.NetraMark Holdings Inc.: NetraMark Announces Change To Board Of Directors3
05.05.Toronto Stock Exchange: NetraMark Holdings Inc. (AIAI) Opens the Market775Toronto, Ontario--(Newsfile Corp. - May 5, 2026) - George Achilleos, Chief Executive Officer, NetraMark Holdings Inc. ("NetraMark", or the "Company") (TSX: AIAI) and their executive team, joined...
► Artikel lesen
04.05.Netramark Holdings Inc: Netramark appoints Theocharous as fractional CMO18
04.05.NetraMark Holdings Inc.: NetraMark Appoints Dr. Panteli Theocharous As Fractional Chief Medical Officer, Strengthening Clinical Leadership To Accelerate Global Adoption of NetraAI290TORONTO, May 04, 2026 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the "Company" or "NetraMark") (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), a premier artificial intelligence (AI) company transforming...
► Artikel lesen
Weiter >>
94 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,2